Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-16-095142)

Filing Details

Accession Number:: 0001104659-16-095142
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-02-09 20:08:35
Reporting Period:: 2016-02-08

Filing Date:: 2016-02-09
Accepted Time:: 2016-02-09 20:08:35
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1651308	Beigene Ltd.	BGNE	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1664990	Ruirong Yuan	C/O Mourant Ozannes Corporate Services 94 Solaris Avenue Camana Bay E9 KY1-1108	Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Ordinary Shares	Acquisiton	2016-02-08	130,000	$1.85	130,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

These ordinary shares are in the form of American Depositary Shares ("ADSs"). Each ADS represents 13 ordinary shares of the Issuer.
These ordinary shares in the form of the ADSs were purchased through a directed share program in connection with the initial public offering of the Issuer.
Calculated based on the initial public offering price of $24.00 per ADS divided by 13, the then ordinary share-to-ADS ratio.